Day 1, Friday, 13 April 2012 |
1330 – 1425 |
Opening Plenaries
Moderator: Soon Thye LIM |
| 1335 – 1400 |
Cancer genome, targeted therapy, and personalised medicine
Norman WOLMARK, USA |
| 1400 – 1425 |
Recent Advances in Translational Research in Asia
Bin Tean TEH, Singapore |
1425 – 1510 |
Teatime symposium 1 |
Teatime symposium 2 |
1510 – 1540 |
Tea break |
| |
Supportive Oncology
Moderator: Cheng Har YIP |
Prevention
Moderator: Miah Hiang TAY |
| 1540 – 1605 |
Hot flashes the role of stellate ganglion blocks and the effect of Tamoxifen on estrogen levels and mechanisms of action
Eugene G LIPNOV, USA |
Integrative interventions for men with early stage prostate cancer
Dean ORNISH, USA |
| 1605 – 1630 |
How Psychosocial research informs cancer care
Lesley FALLOWFIELD, UK |
Value of National Cancer Screening Programmes in Asia – the experiences of Korea
Eun-Cheol PARK, Korea |
| 1630 – 1645 |
Q & A |
Q & A |
Day 2, Saturday, 14 April 2012 |
| |
Gastrointestinal Cancer Suite |
Women's Health Suite |
Genitourinary Cancer Suite |
Haematological-Oncology |
Thoracic Cancer |
Translational Oncology |
|
Colorectal GI Symposium 1
Moderator: Yoon Koo KANG |
BC Symposium 1 - Triple negative breast cancer - translating genomics into therapeutics
Moderator: Masakazu TOI |
GU Symposium 1- renal cell cancer
Moderator: Bin Tean THE |
HO Symposium 1
Moderator: Soon Thye LIM |
Thoracic
Cancer Symposium 1
Moderator: Darren LIM |
Translational Oncology
Moderator: Iain TAN |
| 0845 - 0910 |
Management of Stage II Colorectal Cancer
Harpreet WASAN, UK |
Pathological features and molecular profiles of basal-like and triple negative breast cancer
Jorge REIS-FILHO, UK |
Predictive models for managing renal cell cancer: from the many to the few
Min Han TAN, Singapore |
Novel biomarkers in T-cell lymphomas
Kevin TAY, Singapore |
Tumor Initiating Cells in Lung Cancer - Fact or fiction and therapeutic implications
Bing LIM, Singapore
|
Prospective strategies to treat drug resistant cancers
Louis CHOW, Hong Kong |
| 0910 - 0935 |
Targeted agents in the management of inoperable advanced colorectal cancer
Caio ROCHA LIMA, USA |
Predictors of survival of TNBC in a multiethnic Asian country
Cheng-Har YIP, Malaysia |
Role of Cytoreductive surgery in RCC in the era of TKI
Edmund CHIONG, Singapore |
BV reactivation during chemotherapy for lymphomas
Won-Seog KIM, Korea |
Target therapy in advanced NSCLC in East Asia
Shun LU, China |
Translating basic science into cancer therapeutics – The pivotal role of phase I trials in Asia
Daniel TAN, Singapore |
| 0935 - 1000 |
Access to colorectal cancer care in SE Asia
Gilberto LOPES, Singapore |
Strategies for management of TNBC
Nan Soon WONG Singapore |
Strategies in metastatic RCC
Noan Minh CHAU, Singapore |
Updates on treatment of NK-cell neoplasms
Yok-Lam KWONG, Hong Kong |
Epidemiology of East Asian Lung Cancer
Adeline SEOW, Singapore |
How understanding angiogenesis has led to new therapeutics
Yi-Long WU, China |
| 1000 - 1010 |
Q & A |
1015 - 1100 |
Teatime symposium 3 |
Teatime symposium 4 |
1100 – 1120 |
Tea break |
| |
Hepatobiliary GI Symposium 2
Moderator: Gilberto LOPES |
BC Symposium 2 - Personalised treatment of breast cancer
Moderator: Cheng Har YIP |
GU Symposium 2
Moderator: Miah Hiang TAY |
Haematological-Oncolog
Moderator: Yok Lam KWONG |
Thoracic
Cancer
Moderator: Shun LU |
Translational Oncology
Moderator: Louis CHOW |
| 1120 - 1145 |
Management of locally advanced pancreatic cancer
Caio ROCHA LIMA, USA |
Pharmacogenetics in tailoring breast cancer therapy - the impact of race
Soo Chin LEE, Singapore |
Future potential in the management of RCC
Bin Tean TEH, Singapore |
Impacts of molecular alterations on myeloma treatment
Wee Joo CHNG, Singapore |
Concurrent chemoradiation strategies for locally advanced nsclc
Jay LU, Singapore
|
Next generation technologies that are employed for discovery of cancer biomarkers : The view from the bench
Patrick TAN, Singapore |
| 1145 - 1210 |
Asian perspectives in the management of advanced pancreatic cancer
Takuji OKUSAKA, Japan |
Targeting response to systemic treatment– the search for biomarkers
Masakazu TOI, Japan |
Neoadjuvant chemotherapy vs neoadjuvant chemoRT vs surgery for locally advanced bladder cancer
Alvin WONG, Singapore |
Significance of molecular changes in acute myeloid leukaemia
Hwei-Fang TIEN, Taiwan |
Advancing surgical management of thoracic malignancies
David HARPOLE, USA |
Biomarker development in retrospective analysis of phase 3 clinical trials: what are the strengths, challenges and pitfalls?
Heike GRABSCH, UK |
| 1210 - 1235 |
Current and Future Management of Advanced Hepatocellular Carcinoma
Ann-Lii CHENG, Taiwan |
Research into new targeting agents
Louis CHOW, Hong Kong |
Decision-making in stage I germ cell tumors - is less equal to more?
Min Han TAN, Singapore |
Treatment of indolent B-cell lymphomas
Soon-Thye LIM, Singapore
|
The future of systemic therapy for thoracic cancers
Ignatius OU, USA |
From bench to bedside: what are the challenges in bringing a biomarker to clinic?
Iain TAN, Singapore |
| 1235 - 1245 |
Q & A |
1300 - 1400 |
Lunch Symposium 1 |
Lunch Symposium 2 |
| |
Esophago-gastric GI Symposium 3
Moderator: Ann Lii CHENG |
Update on Gynae-Oncology Symposium 1
Moderator: Sarikapan WILAILAK |
GU Symposium 3 - prostate cancer
Moderator: Noan Minh CHAU |
Neuro-oncology Cancer
Moderator: Wai Hoe NG |
Head & Neck Cancer
Moderator: Anthony CHAN |
Translational Oncology
Moderator: Patrick TAN |
| 1415 1440 |
Role of pre-operative chemotherapy in esophago-gastric cancer
Geoffrey KU, Singapore |
Hereditary gynaecological cancers – the Asian Perspective
Yin-Ling WOO, Malaysia |
Conundrum of PSA screening
Hong Gee SIM, Singapore |
Individualised surgery for glioma through imaging & navigation
Wai Hoe NG, Singapore |
Systemic therapy for head and neck/NPC
Anthony CHAN, Hong Kong |
TO Symposium 3 |
| 1440 - 1505 |
Palliative stent insertion for obstructive lesions in upper GI cancers
Ho Young SONG, Korea |
Pelvic mass risk assessment for ovarian cancer
Richard MOORE, USA |
More Hormone therapy or Chemotherapy in Castrate Resistant Prostate Cancer
Akhil CHOPRA, Singapore |
Personalised systemic treatment for high grade glioma - are we there yet?
Chee Kian THAM, Singapore |
Treatment of locally advanced head and neck cancer, including nasopharyngeal cancer
Jean BOURHIS, France |
Making sense of the vast molecular information for clinical decision making in colorectal cancer
Brigette MA, Hong Kong |
| 1505 - 1530 |
Management of Advanced Gastric Cancer: 1st line and beyond
Yoon-Koo KANG, Korea |
Multimodality treatment in cervical cancer
Sarikapan WILAILAK, Thailand |
Protecting the Bone in Prostate Cancer
Miah Hiang TAY, Singapore |
Modern radiotherapy as part of personalised therapy in high grade glioma
Michael BRADA, UK |
Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial
Jun MA, China |
How molecular pathology has provided new insights into carcinogenesis and molecular heterogeneity of Hepatocellular carcinoma
Xin Yuan GUAN, Hong Kong |
| 1530 - 1545 |
Q & A |
1545 – 1630 |
Teatime symposium 5 |
Teatime symposium 6 |
1630 – 1700 |
Tea Break |
1700 – 1800 |
The Lancet Oncology: Editor’s Choice Poster Awards: Oral Presentations |
1800 – 1815 |
The Lancet Oncology: Editor’s Choice Poster Awards: Price Giving Ceremony |
Day 3, Sunday, 15 April 2012 |
|
Palliative Care |
Melanoma/Sarcoma |
| 0830 – 0900 |
Comparative perspectives on end-of-life and palliative care in Asia and globally
Sheila PAYNE, UK |
Latest advances in melanoma therapeutics
James LARKIN, UK |
| 0900 – 0930 |
Treating cancer pain and/or breakthroughs in cancer pain
Andrew DAVIES, UK |
Latest advances in sarcoma genomics and therapeutic targets
Jean-Yves BLAY, France |
| 0930 – 0945 |
Q & A |
Q & A |
0945 – 1030 |
Tea break |
| 1030 - 1230 |
Breakout Session |
|
Breakout 1: Treatment guidelines for Asian patients with renal-cell and biliary tract cancers
Moderator: Bin Tean Teh |
Breakout 2: Treatment guidelines for supportive, palliative, and end-of-life care for Asian patients with cancer
Moderators: Sheila Payne, Andrew Davies |
Breakout 3: Treatment guidelines for Asian patients with colorectal cancer
Moderator: Gilberto Lopes |
Breakout 4: Ethical issues in supportive and palliative oncology
Moderators: Alastair Campbell, Thomas Murray |
Breakout 5: Talking to patients about early phase clinical-trial enrolment: a communication skills workshop for healthcare professionals
Facilitator: Lesley Fallowfield |
|
Bin Tean Teh, Singapore |
|
• Screening for colorectal cancer
• Surgical treatment of colorectal cancer including the management of resectable metastases
• Adjuvant treatment for stage II and III colorectal cancer
• Management of metastatic colorectal cancer
Gilberto Lopes, Singapore; Ann-Lii Cheng, Taiwan; Yoon-Koo Kang, South Korea |
Ethical issues in the care of the chronically ill cancer patient and the dying cancer patient
Jacqueline Chin, Singapore, and Nancy Berlinger, USA |
Discussing early phase cancer trials with patients with life-limiting disease is challenging; many such trials offer little likelihood of personal benefit yet patients often have unrealistic expectations and misconceptions about therapeutic aims. This interactive workshop will include:-
• A presentation of a study examining what oncologists thought that they had said and what patients thought that they had heard during interviews about Phase 1 trial entry.
• Relevant exercises on communication about phase I & II trials.
• A group discussion around DVD clips of doctors talking with patients and relatives about trial entry.
Lesley Fallowfield, UK |
|
Miah Hiang Tay, Singapore |
|
Access to palliative care in Singapore and other selected Asian nations: law, policy, and economics
Calvin Wai-Loon Ho, Singapore, and Michael K Gusmano, USA |
|
Noan Minh Chau, Singapore |
Palliative care nursing in Asia
Edward Poon, Singapore |
A Korean case study (in collaboration with the Korean Society of Medical Ethics) |
|
|
International models of palliative and end-of-life care
Sheila Payne, UK |
Panel discussion: Good care for patients with advanced cancer—what are the local, regional, and global priorities? |
|
|
Supportive care in oncology
Andrew Davies, UK |
|
